Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-29

Clinical Trial Results: Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating haploidentical bone marrow transplantation in patients with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • haploidentical bone marrow transplantation

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-04-29